2020
DOI: 10.1096/fasebj.2020.34.s1.04675
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Mechanisms of Hypoxia‐Induced Extracellular Vesicle Release

Abstract: Background Extracellular vesicles (EVs) are released by many cells and provide a mechanism for intercellular communication in autocrine and paracrine fashion. EVs of various sizes, namely microvesicles (ranging from 100–1000 nm) or exosomes (with sizes between 30–150 nm) are released by most eukaryotic cells. EVs are known to contain bioactive molecules including proteins lipids and nucleic acids including miRNAs and LNC RNAs that regulate gene expression and cell functions in recipient cells. For example, tum… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…As tumors progress, they need to recruit new blood vessels to ensure a sufficient supply of oxygen and nutrients; this process requires the release of neovascularization-stimulating factors 93 and EVs have been implicated in this process. Hypoxia, which impact angiogenesis, tumor progression, and immune tolerance, has been shown to increase EVs release from cancer cells 106 , 107 . Secondly, the presence of matrix MMPs also allows for the direct modulation of the ECM by EVs in the primary tumor microenvironment and metastatic spread, contributing to ECM degradation to provide spaces for blood vessel recruitment.…”
Section: Novel Mediators Of Ecm Remodelingmentioning
confidence: 99%
“…As tumors progress, they need to recruit new blood vessels to ensure a sufficient supply of oxygen and nutrients; this process requires the release of neovascularization-stimulating factors 93 and EVs have been implicated in this process. Hypoxia, which impact angiogenesis, tumor progression, and immune tolerance, has been shown to increase EVs release from cancer cells 106 , 107 . Secondly, the presence of matrix MMPs also allows for the direct modulation of the ECM by EVs in the primary tumor microenvironment and metastatic spread, contributing to ECM degradation to provide spaces for blood vessel recruitment.…”
Section: Novel Mediators Of Ecm Remodelingmentioning
confidence: 99%
“…EVs of various sizes, namely microvesicles (ranging from 100-1000 nm) or exosomes (with sizes between 30-150 nm) are released by most eukaryotic cells [147]. Evidences suggested that therapeutic effectiveness of pluripotent stem cell might be a consequence of the paracrine action of EVs [148].…”
Section: The Use Of Mirnas In Nanotherapeuticsmentioning
confidence: 99%